In addition, GLP-1 receptor agonists like Semaglutide and Tirzepatide are currently FDA-approved for weight management and blood sugar law, thanks to substantial professional tests validating their efficiency. In metabolic wellness, incretin peptides like GLP-1 analogues effectively manage blood sugar level and cause weight loss. Anti-infective peptides are under development to...